Speakers, Chairs, and Special Attendees:
Jerry Adams, Walter & Eliza Hall Institute of Medical Research, Australia
James Allison, UT MD Anderson Cancer Center
Alan Ashworth, UCSF Helen Diller Family Comprehensive Cancer Center
Allan Balmain, UCSF Helen Diller Family Comprehensive Cancer Center
David Baltimore, California Institute of Technology
Mariano Barbacid, CNIO, Spanish National Cancer Research Center, Spain
Cori Bargmann, The Rockefeller University
Rene Bernards, Netherlands Cancer Institute, The Netherlands
Anton Berns, Netherlands Cancer Institute, The Netherlands
J. Michael Bishop, University of California, San Francisco
Joan Brugge, Harvard Medical School
Lewis Cantley, Dana-Farber Cancer Institute
Arul Chinnaiyan, University of Michigan Rogel Cancer Center
Suzanne Cory, Walter & Eliza Hall Institute of Medical Research, Australia
Angela Creager, Princeton University
Riccardo Dalla-Favera, Columbia University
Hugues de Thé, Collège de France and Hospital St. Louis, France
John Dick, Princess Margaret Cancer Centre
Brian Druker, OHSU Knight Cancer Institute
Robert Eisenman, Fred Hutchinson Cancer Center
Stephen Elledge, Harvard Medical School
Ronald Evans, Salk Institute
Eric Fearon, University of Michigan Rogel Cancer Center
Montserrat Garcia-Closas, The Institute of Cancer Research, UK
Levi Garraway, Genentech
Todd Golub, Broad Institute
Thomas Graf, Center for Genomic Regulation
Joe Gray, Oregon Health & Science University
Carol Greider, University of California, Santa Cruz
Terri Grodzicker, Cold Spring Harbor Laboratory
Ed Harlow, Harvard Medical School
Tony Hunter, Salk Institute
Tyler Jacks, MIT
William Kaelin, HHMI/ Dana-Farber Cancer Institute
Mary Claire King, University of Washington
Richard Klausner, Altos Lab
Eric Lander, Broad Institute of MIT and Harvard
David Lane, Karolinska Institute
Michelle Le Beau, Cancer Prevention & Research Institute of Texas
Arnold Levine, Institute for Advanced Study
Ross L. Levine, Memorial Sloan Kettering Cancer Center
Douglas Lowy, National Cancer Institute
Guillermina (Gigi) Lozano, MD Anderson Cancer Center
Elaine Mardis, Nationwide Children's Hospital/Ohio State University College of Medicine
G. Steven Martin, University of California at Berkeley
Frank McCormick, UCSF Helen Diller Family Comprehensive Cancer Center
Matthew Meyerson, Dana-Farber Cancer Institute
John Minna, UT Southwestern Medical Center
Felix Mitelman, Lund University, Sweden
Deborah Morrison, National Cancer Institute
Siddartha Mukherjee, Columbia University Vagelos College of Physicians & Surgeons
Benjamin Neel, NYU Grossman School of Medicine
Roel Nusse, Stanford University
Olufunmilayo Olopade, University of Chicago Medicine
William Pao, Revelio Therapeutics
Luis Parada, Memorial Sloan Kettering Cancer Center
Richard Peto, University of Oxford, UK
Bruce Ponder, Cancer Research UK, UK
Carol Prives, Columbia University
Aviv Regev, Genentech
Andrew Roberts, Peter MacCallum Cancer Centre, Australia
Jessica Roberts, Emory School of Law
Martine Roussel, St. Jude Children's Research Hospital
Charles Sawyers, Memorial Sloan Kettering Cancer Center
Yossi Schlessinger, Yale University
Edward Scolnick, Broad Institute of MIT and Harvard
Charles J. Sherr, St. Jude Children's Research Hospital
Kevan Shokat, UCSF Helen Diller Family Comprehensive Cancer Center
Tania Simoncelli, Chan Zuckerberg Initiative
Lillian Siu, Princess Margaret Cancer Centre, Canada
Dennis Slamon, UCLA Jonsson Comprehensive Cancer Center
Louis Staudt, National Cancer Institute
Bruce Stillman, Cold Spring Harbor Laboratory
Michael Stratton, Wellcome Trust Sanger Institute, UK
Charlie Swanton, Francis Crick Institute, UK
Craig Thompson, Memorial Sloan Kettering Cancer Center
David Tuveson, Cold Spring Harbor Laboratory
Harold Varmus, Weill Cornell Medicine
Peter Vogt, Scripps Research Institute
Robert Weinberg, Whitehead Institute for Biomedical Research
Irving Weissman, Stanford University
Michael Wigler, Cold Spring Harbor Laboratory
These meetings bring together multiple generations of scientists and historians to present and discuss major developments in the biological sciences. The proceedings are filmed and placed on a dedicated website maintained by the CSHL Archives to serve as documentary material for historians, scientists, journalists, teachers, and students.
Like its predecessors, the meeting we are planning will provide a unique opportunity to examine the development of the field of cancer genetics in depth, to share the personal stories that are often missing from reports published in scientific journals, and to discuss the consequences and future prospects for this field of science.
We have applied for funds from industry and other sponsors to partially offset registration costs for some attendees. Please apply in writing via email to Kelley McGrath and state your financial needs.
Social Media:
The designated hashtag for this meeting is #cshhist25. Note that you must obtain permission from an individual presenter before live-tweeting or discussing his/her talk, poster, or research results on social media. Click the Policies tab above to see our full Confidentiality & Reporting Policy.
Financial support provided by:
In-Person Fees:
Academic/Media Private Room/Private Bath Package: $1505
Academic/Media Private Room/Shared Bath Package: $1415
Academic Shared Room Package: $1300
Academic/Media No-Housing Package: $990
Student Package/Double Occupancy: $1195
Student Package/No Housing Package: $885
Corporate Private Room/Private Bath Package: $1935
Corporate No-Housing Package: $1420
*Student Housing is default double occupancy. Please inquire about availability and fees to upgrade to a private room.
NOTE: We cannot guarantee housing will be on campus
Room package reservations close 2 weeks before the meeting start date
Virtual Participation: Includes access to the oral sessions via Zoom, the digital poster gallery, the Slack discussion workspace, and the Leading Strand video archive. If you are submitting an abstract for an oral or poster presentation, please plan to attend the meeting in-person.
Presenters: Individuals submitting abstracts and facing financial barriers should first request financial aid (see above). Permission to present your talk or poster virtually will be given only in exceptional circumstances and on a case-by-case basis. If you think you are eligible for an exemption from the requirement to present in person, please provide a justification in writing via email to Kelley McGrath
Non-presenting participants: We plan to broaden access to the conference by allowing certain categories of non-presenting participants to attend virtually at reduced fees. Categories include:
1. Individuals from low & middle-income countries;
2. Individuals from non-LMIC countries in Asia, Australasia, Africa, or South America;
3. Individuals from US & Canadian minority-serving institutions;
4. Individuals with a demonstrable financial barrier;
5. Individuals with family obligations or other special circumstances.
For categories 4 & 5 above, please provide a justification via email to
Kelley McGrath
Virtual Fees
Academic Virtual Package $315
Grad Student Virtual Package: $185
Corporate Virtual Package: $460
Late Fee (Registrations submitted after 5:00 p.m. ET on March 20)
Late Academic Virtual Package: $415
Late Student Virtual Package: $285
Late Corporate Virtual Package: $560